RT Journal Article SR Electronic T1 Efficacy of rituximab in refractory polymyositis. JF The Journal of Rheumatology JO J Rheumatol FD The Journal of Rheumatology SP 1369 OP 1370 VO 32 IS 7 A1 Olivier Lambotte A1 Rami Kotb A1 Gwenola Maigne A1 François-Xavier Blanc A1 Cécile Goujard A1 Jean François Delfraissy YR 2005 UL http://www.jrheum.org/content/32/7/1369.abstract AB We describe the effectiveness of rituximab, an anti-B lymphocyte monoclonal antibody, in a case of refractory polymyositis with interstitial pulmonary disease and anti-Jo-1 autoantibody (antisynthetase syndrome). Rituximab was well tolerated, and its efficacy in inflammatory myositis should be evaluated.